In this review, we summarize more recent therapeutic strategies (myostatin or proteasome inhibition, supplementation with eicosapentaenoic acid (EPA) or ursolic acid, etc.)for counteracting sarcopenia. This evidence concerns the gene MSTN and sarcopenia.